485 related articles for article (PubMed ID: 23312578)
1. CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase.
Ito T; Hashizume H; Shimauchi T; Funakoshi A; Ito N; Fukamizu H; Takigawa M; Tokura Y
J Dermatol Sci; 2013 Feb; 69(2):140-7. PubMed ID: 23312578
[TBL] [Abstract][Full Text] [Related]
2. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
[TBL] [Abstract][Full Text] [Related]
3. Antihistaminic drug olopatadine downmodulates T cell chemotaxis toward CXCL10 by reducing CXCR3 expression, F-actin polymerization and calcium influx in patients with alopecia areata.
Ito T; Fujiyama T; Hashizume H; Tokura Y
J Dermatol Sci; 2013 Oct; 72(1):68-71. PubMed ID: 23735349
[No Abstract] [Full Text] [Related]
4. Interferon-gamma-deficient mice are resistant to the development of alopecia areata.
Freyschmidt-Paul P; McElwee KJ; Hoffmann R; Sundberg JP; Vitacolonna M; Kissling S; Zöller M
Br J Dermatol; 2006 Sep; 155(3):515-21. PubMed ID: 16911275
[TBL] [Abstract][Full Text] [Related]
5. Pro-inflammatory Vδ1
Uchida Y; Gherardini J; Schulte-Mecklenbeck A; Alam M; Chéret J; Rossi A; Kanekura T; Gross CC; Arakawa A; Gilhar A; Bertolini M; Paus R
J Dermatol Sci; 2020 Nov; 100(2):129-138. PubMed ID: 33039243
[TBL] [Abstract][Full Text] [Related]
6. Induction of cellular immunity against hair follicle melanocyte causes alopecia.
Nagai H; Oniki S; Oka M; Horikawa T; Nishigori C
Arch Dermatol Res; 2006 Aug; 298(3):131-4. PubMed ID: 16786344
[TBL] [Abstract][Full Text] [Related]
7. Alopecia areata: a tissue specific autoimmune disease of the hair follicle.
Gilhar A; Kalish RS
Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213
[TBL] [Abstract][Full Text] [Related]
8. Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus.
Wenzel J; Wörenkämper E; Freutel S; Henze S; Haller O; Bieber T; Tüting T
J Pathol; 2005 Mar; 205(4):435-42. PubMed ID: 15685590
[TBL] [Abstract][Full Text] [Related]
9. Alopecia areata in C3H/HeJ mice involves leukocyte-mediated root sheath disruption in advance of overt hair loss.
McElwee KJ; Silva K; Boggess D; Bechtold L; King LE; Sundberg JP
Vet Pathol; 2003 Nov; 40(6):643-50. PubMed ID: 14608017
[TBL] [Abstract][Full Text] [Related]
10. The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection.
Larrubia JR; Calvino M; Benito S; Sanz-de-Villalobos E; Perna C; Pérez-Hornedo J; González-Mateos F; García-Garzón S; Bienvenido A; Parra T
J Hepatol; 2007 Nov; 47(5):632-41. PubMed ID: 17560677
[TBL] [Abstract][Full Text] [Related]
11. Diphenylcyclopropenone treatment of alopecia areata induces apoptosis of perifollicular lymphocytes.
Herbst V; Zöller M; Kissling S; Wenzel E; Stutz N; Freyschmidt-Paul P
Eur J Dermatol; 2006; 16(5):537-42. PubMed ID: 17101475
[TBL] [Abstract][Full Text] [Related]
12. Serum granulysin as a possible key marker of the activity of alopecia areata.
Ono S; Otsuka A; Yamamoto Y; Kataoka TR; Koyanagi I; Miyachi Y; Kabashima K
J Dermatol Sci; 2014 Jan; 73(1):74-9. PubMed ID: 24035442
[TBL] [Abstract][Full Text] [Related]
13. CXCR3 Blockade Inhibits T Cell Migration into the Skin and Prevents Development of Alopecia Areata.
Dai Z; Xing L; Cerise J; Wang EH; Jabbari A; de Jong A; Petukhova L; Christiano AM; Clynes R
J Immunol; 2016 Aug; 197(4):1089-99. PubMed ID: 27412416
[TBL] [Abstract][Full Text] [Related]
14. Association of Th1/Th2-related chemokine receptors in peripheral T cells with disease activity in patients with multiple sclerosis and neuromyelitis optica.
Shimizu Y; Ota K; Kubo S; Kabasawa C; Kobayashi M; Ohashi T; Uchiyama S
Eur Neurol; 2011; 66(2):91-7. PubMed ID: 21846991
[TBL] [Abstract][Full Text] [Related]
15. Lesional infiltration of mast cells, Langerhans cells, T cells and local cytokine profiles in alopecia areata.
Zhang X; Zhao Y; Ye Y; Li S; Qi S; Yang Y; Cao H; Yang J; Zhang X
Arch Dermatol Res; 2015 May; 307(4):319-31. PubMed ID: 25638328
[TBL] [Abstract][Full Text] [Related]
16. Early stage alopecia areata is associated with inflammation in the upper dermis and damage to the hair follicle infundibulum.
Zhang B; Zhao Y; Cai Z; Caulloo S; McElwee KJ; Li Y; Chen X; Yu M; Yang J; Chen W; Tang X; Zhang X
Australas J Dermatol; 2013 Aug; 54(3):184-91. PubMed ID: 23808570
[TBL] [Abstract][Full Text] [Related]
17. Altered T cell subpopulations and serum anti-TYRP2 and tyrosinase antibodies in the acute and chronic phase of alopecia areata in the C3H/HeJ mouse model.
Hashimoto K; Yamada Y; Fujikawa M; Sekiguchi K; Uratsuji H; Mori S; Watanabe H; Matsumoto T
J Dermatol Sci; 2021 Oct; 104(1):21-29. PubMed ID: 34511266
[TBL] [Abstract][Full Text] [Related]
18. CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients.
Enghard P; Humrich JY; Rudolph B; Rosenberger S; Biesen R; Kuhn A; Manz R; Hiepe F; Radbruch A; Burmester GR; Riemekasten G
Arthritis Rheum; 2009 Jan; 60(1):199-206. PubMed ID: 19116922
[TBL] [Abstract][Full Text] [Related]
19. Alopecia areata: infiltration of Th17 cells in the dermis, particularly around hair follicles.
Tanemura A; Oiso N; Nakano M; Itoi S; Kawada A; Katayama I
Dermatology; 2013; 226(4):333-6. PubMed ID: 23838575
[TBL] [Abstract][Full Text] [Related]
20. Resolving lesions in human cutaneous leishmaniasis predominantly harbour chemokine receptor CXCR3-positive T helper 1/T cytotoxic type 1 cells.
Geiger B; Wenzel J; Hantschke M; Haase I; Ständer S; von Stebut E
Br J Dermatol; 2010 Apr; 162(4):870-4. PubMed ID: 19906074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
